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Microenvironment plays an important role for stem cell proliferation and diﬀerentiation. Macromolecular crowding (MMC) was
recently shown to assist stem cells in forming their own matrix microenvironment in vitro. The ability of MMC to support adipose
stem cell (ASC) proliferation, metabolism, and multilineage diﬀerentiation was studied under diﬀerent conditions: fetal bovine
serum- (FBS-) and human serum- (HS-) based media and xeno- and serum-free (XF/SF) media. Furthermore, the
immunophenotype of ASCs under MMC was evaluated. The proliferative capacity of ASCs under MMC was attenuated in each
condition. However, osteogenic diﬀerentiation was enhanced under MMC, shown by increased deposition of mineralized matrix
in FBS and HS cultures. Likewise, signiﬁcantly greater lipid droplet accumulation and increased collagen IV deposition indicated
enhanced adipogenesis under MMC in FBS and HS cultures. In contrast, chondrogenic diﬀerentiation was attenuated in ASCs
expanded under MMC. The ASC immunophenotype was maintained under MMC with signiﬁcantly higher expression of CD54.
However, MMC impaired metabolic activity and diﬀerentiation capacity of ASCs in XF/SF conditions. Both the supportive and
inhibitory eﬀects of MMC on ASC are culture condition dependent. In the presence of serum, MMC maintains ASC
immunophenotype and enhances adipogenic and osteogenic diﬀerentiation at the cost of reduced proliferation.
1. Introduction
Inside the human body, cells are surrounded by a micro-
environment that is physiologically crowded with soluble
factors, other cells, and extracellular matrix. The typical
serum protein concentration of biological ﬂuids are, for
example, 30–70 g/L in interstitial ﬂuid, 80 g/L in blood
plasma, and even 200–350 g/L in cell cytoplasm [1]. In
contrast, the typical in vitro serum protein concentration
is 1–10 g/L, and the composition is maintained plain and
simple with only the most essential components, for
example, attachment and growth factors provided [1].
Thus, this poorly corresponds to the original tissue micro-
environments. The macromolecular crowding (MMC)
method addresses this question by modifying the microen-
vironment and facilitating the formation and remodeling
of the extracellular matrix (ECM) [1, 2]. Macromolecular
crowders function by way of the excluded volume eﬀect
(EVE) [3]. The volume that surrounds a given molecule
becomes unavailable for other molecules, which leads to
higher eﬀective concentrations of diﬀerent macromolecules
in a solution. Furthermore, the amount of EVE is dependent
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on the fractional volume occupancy (FVO), which is deﬁned
as a fraction of the total volume occupied by macromole-
cules. Consequently, MMC inﬂuences many fundamentals,
for example, rates of enzymatic reactions, formation of cyto-
skeleton, cell adhesion, and migration [1, 3–6].
Previously, the eﬀect of MMC on stem cell behavior has
mainly been studied using bone marrow-derived mesenchy-
mal stem cells (BM-MSCs) in fetal bovine serum- (FBS-)
based cultures [2, 7–9]. However, human adipose tissue is
another attractive and abundant source of multipotent stem
cells, known as the adipose stem cells (ASCs). ASCs have
the ability to diﬀerentiate into several cell types of mesoder-
mal origin [10, 11] and have low immunogenicity [12–14]
and immunomodulatory properties [15–18]. Due to these
characteristics, ASCs are promising candidates for clinical
applications and several clinical trials are currently ongoing
as reviewed [19, 20].
Stem cell therapies often require large numbers of cells
and usually in vitro cell expansion preceding in vivo
implantation. Traditionally, FBS has been used in stem cell
cultures. For clinical purposes, animal-derived components
in culture media raise safety concerns related to xenoge-
neic contaminations and transfer of xenogeneic infections
upon cell transplantation [21, 22]. Also, antibodies against
bovine antigens may be elicited by repeated administration
of cells, which will aﬀect the eﬃcacy of cell-based treatments.
Therefore, xeno-free (XF) alternatives such as human serum-
(HS-) [23–25] or platelet- (PL-) derived supplements [26–28]
as well as fully deﬁned XF and serum-free (SF) conditions
[29, 30] have been developed for ASC culture. HS-based
approaches have not only potential for clinical use but also
disadvantages, for example, limited availability and lot-to-
lot variation [31]. These challenges can be avoided by
replacing undeﬁned and/or animal-derived components
with deﬁned XF/SF reagents that have a reproducible com-
position [29, 30]. Moreover, careful characterization of
ASC behavior in clinically relevant in vitro culture condi-
tions is important for the progress of cell-based therapies.
The aim of this study was to investigate the potential of
MMC in supporting ASC proliferation and multilineage
diﬀerentiation capacity and analyze the MMC eﬀect on
immunophenotype and morphology of ASCs in diﬀerent
culturing conditions considering clinical applications. In
the current study, cell isolation and expansion were carried
out in parallel in FBS- and HS-containing media and com-
pared with those in deﬁned XF/SF conditions. The MMC
method has not been previously reported in ASC cultures
and especially the use of diﬀerent culture conditions under
MMC is a novel approach. Our current study demonstrates
both supportive and inhibitory aspects of the MMC on
ASC cultures in diﬀerent serum conditions and shows prom-
ising results of osteogenic and adipogenic diﬀerentiation of
ASCs under MMC in FBS and HS cultures.
2. Materials and Methods
2.1. Ethical Considerations and Tissue Procurement. The
collection of adipose tissue was approved by the ethics
committee of the Pirkanmaa Hospital District in Tampere,
Finland (ethical approval R03058). Adipose tissue samples
were acquired during elective surgical procedures performed
in the Department of Plastic Surgery, Tampere University
Hospital, Tampere, Finland, with the patient’s written
consent, and the study was conducted in accordance with
the Declaration of Helsinki 1975, revised in Hong Kong
1989. ASCs were isolated from adipose tissue samples that
were obtained from four female donors (mean age 52± 12).
2.2. Isolation and Expansion of ASCs. ASCs were isolated
from adipose tissue samples into three diﬀerent culture
conditions: medium containing FBS, HS, or deﬁned XF/SF
culture conditions. Isolation of ASCs was carried out using
a mechanical and enzymatic method as described previ-
ously [10, 11, 30, 32]. Brieﬂy, the adipose tissue was
minced manually into small fragments and digested with
collagenase NB 6 GMP Grade (SERVA Electrophoresis
GmbH, Heidelberg, Germany, http://www.serva.de). The
digested tissue was centrifuged and ﬁltered in sequential
steps to separate the ASCs from the surrounding tissue. For
FBS and HS conditions, Dulbecco’s modiﬁed Eagle’s medium
(DMEM)/F-12 1 : 1 (Life Technologies, Rockville, MD) was
supplemented with 1% L-alanyl-L-glutamine (GlutaMAX I;
Life Technologies), 1% antibiotics (p/s; 100U/mL penicil-
lin, 0.1mg/mL streptomycin; Lonza, Walkersville, MD,
http://www.lonza.com), and either 10% FBS (Life Technol-
ogies) or 10% HS (human serum type AB; Lonza). For
XF/SF conditions, cells were isolated as described pre-
viously [30]. Brieﬂy, after the isolation steps described
previously, cells were seeded in carboxyl-coated ﬂasks (Pure-
Coat Carboxyl T75; BD Biosciences, Franklin Lakes, NJ,
http://www.bdbiosciences.com) and expanded in StemPro®
MSC SFM XenoFree (Life Technologies) supplemented with
1% GlutaMAX I, 0.3% antibiotics, and 10% StemPro MSC
SFM XenoFree supplement. From passage 1 onwards, XF/
SF cells were expanded in a StemPro MSC SFM XenoFree
medium supplemented with CELLstart CTS coating (Life
Technologies) according to the manufacturer’s instructions.
ASCs were detached in all conditions using TrypLE Select
(Life Technologies). Culture media formulations used for
FBS, HS, and XF/SF cultures are presented in Table 1. Cells
from four donors were separately analyzed for immunophe-
notype, proliferation, metabolic activity, and diﬀerentiation
toward osteogenic and chondrogenic lineage, while adipo-
genic diﬀerentiation was performed with three donor cells
in FBS, HS, and XF/SF conditions.
2.3. Macromolecular Crowding in ASC Culture. A cocktail
of macromolecules containing FicollTM400 (PM400, 17-
0300-50; GE Healthcare, Bio-Sciences AB) and FicollTM70
(PM70, 17-0310-50; GE Healthcare, Bio-Sciences AB) was
dissolved in culture media at room temperature with gentle
agitation. Fractional volume occupancy of 17% (v/v) was
achieved with concentrations 37.5mg/mL of FicollTM70
and 25mg/mL of FicollTM400 as described previously [3].
The MMC culture media was sterile ﬁltered before use. From
passage 1 onwards, the FBS- and HS-expanded cells were
divided into two populations and one-half was expanded in
standard media and the other half under MMC until the
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analyses. For technical reasons, the XF/SF-expanded cells
were divided into two populations from passage 2 onwards
and expanded in standard XF/SF media and under MMC
until the analyses. The workﬂow of the experiments is
illustrated in Figure 1.
2.4. Adipose Stem Cell Immunophenotype. ASCs expanded
in standard conditions and under MMC in FBS, HS,
and SF/XF were analyzed using ﬂow cytometry in passage
4 (FACSAria; BD Biosciences, Erembodegem, Belgium) to
determine the immunophenotype of the cells. Monoclonal
antibodies (MAbs) against CD11a-allophycocyanin (APC),
CD80-phycoerythrin (PE), CD86-PE, CD105-PE (R&D
Systems Inc., Minneapolis, MN, USA), CD3 (PE), CD14-
phycoerythrin-cyanine (PECy7), CD19-PECy7, CD45RO-
APC, CD54-ﬂuorescein isothiocyanate (FITC), CD73-PE,
CD90-APC (BD Biosciences), CD34-APC, and HLA-DR-
PE (ImmunoTools GmbH, Friesoythe, Germany) were used.
Analysis was performed on 10000 cells per sample, and
unstained cell samples were used to correct for background
autoﬂuorescence [32].
2.5. ASC Morphology, Metabolic Activity, and Proliferation.
ASCs were observed by light microscopy to detect morpho-
logical changes during cell expansion in FBS, HS, and XF/SF
conditions in standard media and under MMC. The meta-
bolic activity of ASCs in the aforementioned conditions
was assessed with Cell Counting Kit-8 (CCK-8) (Takara
Bio Inc., Shiga, Japan) in passage 4. The assay is based on the
cleavage of tetrazolium salts bymitochondrial dehydrogenase
Table 1: Culture media formulations used for cell expansion and diﬀerentiation assays.
Medium Basal media Serum
Coating/coating-free
supplements
Supplementation
Expansion FBS
DMEM/F-12
(Life Technologies, Gibco,
Rockville, MD)
10% FBS
(Life Technologies)
None
1% GlutaMAX
(GlutaMAX I; Life Technologies),
1% p/s (p/s; 100U/mL penicillin,
0.1mg/mL streptomycin; Lonza)
Expansion HS DMEM/F-12
10% HS (Lonza,
Walkersville, MD)
None 1% GlutaMAX, 1% p/s
Expansion XF/SF
StemPro MSC SFM
(Life Technologies)
None
CELLstart™ coating
(Life Technologies)
1% GlutaMAX, 0,3% p/s,
StemPro MSC SFM XenoFree
supplement (Life Technologies)
Adipogenic
FBS/HS
DMEM/F-12 10% FBS/HS None
For 4 days induction during cyclic
diﬀerentiation: 1% GlutaMAX,
1% p/s, 0.5mM isobutylmethylxanthine
(IBMX; Sigma), 0.2mM indomethacin
(Sigma), 1μM dexamethasone (Sigma),
and 10 μg/mL insulin (Sigma)
Adipogenic
XF/SF
StemPro
MSC SFM
None CELLstart coating
For 4 days induction during cyclic
diﬀerentiation: 1% GlutaMAX, 0,3% p/s,
StemPro MSC SFM XenoFree supplement,
same adipogenic supplements as
in FBS/HS cultures
Osteogenic
FBS/HS
DMEM/F-12 10% FBS/HS None
1% GlutaMAX, 1% p/s,
150μM L-ascorbic acid
2-phosphate (Sigma),
10mM beta-glycerophosphate (Sigma),
10 nM dexamethasone (Sigma)
Ostegenic
XF/SF
StemPro
MSC SFM
None CELLstart coating
1% GlutaMAX, 0,3% p/s,
StemPro MSC SFM XenoFree supplement,
same osteogenic supplements as
in FBS/HS cultures
Chondrogenic
FBS/HS
DMEM/F-12 None None
1% GlutaMAX, 0,2% p/s,
1x ITS + 1 (Sigma), 50μM L-ascorbic acid
2-phosphate, 55 μM sodium pyruvate
(Life Technologies), 23 μM L-proline (Sigma),
10 ng/mL TGF-β (Sigma)
Chondrogenic
XF/SF
StemPro
MSC SFM
None None
1% GlutaMAX, 0,2% p/s, StemPro
MSC SFM XenoFree supplement,
same chondrogenic supplements as
in FBS/HS cultures
FBS: fetal bovine serum; HS: human serum; XF/SF: xeno-free/serum-free; StemPro MSC SFM XenoFree: StemPro mesenchymal stem cell serum-free and
xeno-free media; p/s: penicillin and streptomycin; TGF-β: transforming growth factor beta.
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enzyme, which enables colorimetric assessment of cell
proliferation and metabolic activity. ASCs were seeded in
48-well plates at a density of 2500 cells/cm2, and metabolic/
mitochondrial activity was assessed at 1, 4, 7, and 11 days. In
brief, at each timepoint, the cell culturemediumwas removed,
and DPBS (Dulbecco’s phosphate-buﬀered saline, Lonza,
BioWhittaker, Verviers, Belgium) and CCK-8 reagent were
added 10 : 1. The 48-well plate was incubated for 3 hours at
37°C, and the relative mitochondrial activity was measured
in a microplate reader (Victor 1429 Multilabel Counter;
Wallac; Turku, Finland) at 450nm.
Cell numbers were quantiﬁed using the CyQUANT® cell
proliferation assay kit (Molecular Probes, Invitrogen, Paisley,
UK) in passage 4 as described previously [33]. Brieﬂy, cells
were lysed with 0.1% Triton-X 100 buﬀer (Sigma-Aldrich),
and the supernatant was collected and stored at −80°C until
the ﬁnal analysis. Fluorescence signals were measured with
a microplate reader at 480/520 nm. The metabolic activity
detected by CCK-8 cell proliferation assay was normalized
to the cell number that was quantiﬁed by the CyQUANT cell
proliferation assay kit.
2.6. Trilineage Diﬀerentiation Potential. The osteogenic,
adipogenic, and chondrogenic diﬀerentiation potential was
evaluated in XF/SF conditions versus HS and FBS media in
standard conditions and under MMC in passage 4. The
osteogenic and adipogenic diﬀerentiation capacity of ASCs
was analyzed in four diﬀerent treatment groups (I–IV) that
are illustrated in Figure 1 and the chondrogenic diﬀerentia-
tion was studied in two diﬀerent treatment groups (II and
IV) (Figure 1). The culture media formulations used for
diﬀerentiation assays are shown in Table 1 and the workﬂow
of the experiments is illustrated in Figure 1.
For osteogenic diﬀerentiation, cells were seeded on
12-well plates at a density of 2.0× 103 cells/cm2 in expansion
media and the induction was initiated 48 h after cell seeding.
After 28 days of induction, the osteogenic diﬀerentiation was
quantiﬁed with the Alizarin red S method as described
previously [25]. Brieﬂy, cells were ﬁxed with 4% paraformal-
dehyde (PFA) and stained with 2% Alizarin red solution
(Sigma-Aldrich; pH4.2), followed by several washes with dis-
tilled water. Light microscopic cell imaging was used for
qualitative analysis and 100mM cetylpyridinium chloride
extraction (3 h incubation; Sigma-Aldrich) was used for
quantitative analysis. The dye intensity was determined at
540 nm with a microplate reader.
For adipogenic diﬀerentiation, ASCs were seeded on
24-well plates at an initial density of 1.05× 104 cells/cm2.
Adipogenic diﬀerentiation was initiated when the cells
reached conﬂuence as described previously [2] using three
cycles of 4 days of induction followed by 3 days of main-
tenance. After 21 days of diﬀerentiation, Nile red staining
and quantitative adherent cytometry were used to assess
the area of cytoplasmic lipid accumulation. In brief, cell
cultures were rinsed with PBS, ﬁxed in 4% formaldehyde
and costained for 30min with 5μg/mL of Nile red (N3013;
Sigma) for cytoplasmic lipid droplets and 0.5μg/mL of DAPI
(D3571, Molecular Probes®; Life Technologies) for nuclear
DNA as previously described [34]. Adherent cytometry was
performed according to a previously described protocol [2].
Brieﬂy, cell images were acquired using 2× magniﬁcation
with a cool-SNAP HQ camera attached to a Nikon TE2000
microscope (Nikon Instruments) and analyzed using the
Metamorph Imaging System Software 6.3v3 (Molecular
Devices). The extent of adipogenic diﬀerentiation was quan-
tiﬁed by area of Nile red ﬂuorescence and normalized to
Expansion
FBS HS XF/SF
+MMC ‒MMC
Differentiation
studies P4
+MMC ‒MMC +MMC ‒MMC
FBS HS XF/SF FBS HS XF/SF FBS HS XF/SF
FBS HS XF/SF
FBS HS XF/SF
Cell number
and metabolic
activity 
±
Immunophenotype
using flow cytometry
MMC and D
P1 P3 P1 P3 P2 P3 P1 P3 P1 P3 P2 P3
Isolation
FBS HS XF/SF
P4 MMC ±P4 MMC
(I) E + + MMC MMC and D(II) E + ‒ MMC MMC and D(III) E ‒ + MMC MMC and D(IV) E ‒ ‒ MMC
Figure 1: The workﬂow of the experiments under diﬀerent culture conditions. The isolation of ASCs was carried out in parallel in FBS- and
HS-containing media and in deﬁned XF/SF conditions. After isolation from passage 1 onwards (FBS and HS conditions) and from passage 2
onwards (XF/SF condition), cells were divided into two populations. One half was expanded in standard media and the other half under
MMC until the proliferation and diﬀerentiation analyses in passage 4. The osteogenic and adipogenic diﬀerentiation capacity of
ASCs was studied in four diﬀerent treatment groups (I–IV) and chondrogenic diﬀerentiation capacity in two treatment groups (II
and IV). FBS, fetal bovine serum; HS, human serum; XF/SF, xeno-free/serum-free; MMC, macromolecular crowding; E±MMC,
expansion under macromolecular crowding/in standard medium; D±MMC, diﬀerentiation under macromolecular crowding/in standard
medium; P1, passage 1.
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nuclei count. End data corresponded to the total area of
lipid droplets present per well normalized to cell number
(μm2/nuclei).
Collagen IV (Col IV) staining was used to evaluate the
deposition of ECM proteins under MMC after 21 days of
adipogenic induction. Brieﬂy, ASCs were ﬁxed with 4%
formaldehyde and blocked with 3% bovine serum albumin
(BSA) in PBS for 1 hour. Immunoﬂuorescence was carried
out using primary antibody for Col IV (ab6586, 1 : 500,
Abcam, Cambridge, UK) and incubated overnight at 4°C in
1% BSA in PBS. The secondary antibody used was a 594 goat
antibody against rabbit (Alexa Fluor A11072, 1 : 400, Molec-
ular Probes, Thermoﬁsher Scientiﬁc). Images were captured
with an IX71 inverted ﬂuorescence microscope (Olympus).
The chondrogenic diﬀerentiation potential was assessed
by micromass culture as described previously [32, 35–37].
Brieﬂy, 8× 104 cells were seeded on a 24-well culture plate
in a 10μL volume and spheroids were allowed to form within
3 hours prior to the addition of chondrogenic induction
medium. After 21 days of chondrogenic induction, diﬀeren-
tiation was conﬁrmed using Alcian blue staining as described
earlier [37]. Brieﬂy, micromass cultures were ﬁxed with 4%
PFA and stored in 70% ethanol. Pellets were dehydrated,
embedded in paraﬃn, and sectioned at 5μm thickness. The
sections were stained with Alcian blue (pH1.0) to verify
the presence of sulfated glycosaminoglycans (GAGs) with
Nuclear Fast Red solution (Biocare Medical, Concord,
MA, USA) as a counterstain.
2.7. Statistical Analyses. Statistical analyses were performed
with IBM SPSS software version 21 (IBM Corp., Armonk,
NY, www.ibm.com). Since the data was not normally distrib-
uted, a nonparametric Mann-Whitney U test was used to
analyze the eﬀect of diﬀerent culture conditions on cell
proliferation rate, cell surface proteins, and diﬀerentiation
potential. The p values weremultiplied by the number of com-
parisons when multiple comparisons were performed. For
proliferation (CyQUANT) and metabolic activity (CCK-8),
the p value was multiplied by 42, and for quantitative AR
and NR staining data, the p value was multiplied by 24
that was a total number of performed comparisons. The
nonparametric Spearman correlation test was used to
study correlation between DNA amounts and metabolic
activity of the cells. The results were considered statistically
signiﬁcant when the p value was less than 0.05. The data
are presented as mean± standard deviation (SD).
3. Results
3.1. The Eﬀect of MMC on Cell Surface Markers. The charac-
teristic immunophenotype of ASCs was maintained under
MMC- and ASC-expressed stem markers CD73, CD90, and
CD105 in all studied conditions (Figure 2(a)). ASCs did
not express CD3, CD11a, CD14, CD19, CD80, CD86,
and HLA-DR in any of the studied conditions (Figure 2(b)).
Interestingly, the expression of CD54 was signiﬁcantly
increased (p < 0 05) under MMC across all culture condi-
tions. On average, ASCs showed low to moderate expression
for hematopoietic progenitor stem cell marker CD34.
Although some variation was observed between culture
conditions, no statistical diﬀerences could be determined
for CD34 due to large donor to donor variation. ASCs were
exposed to MMC during cell expansion from passage 1 to
4 in FBS and HS media (Figure 1). However, MMC did
not support the proliferation of XF/SF-expanded ASCs.
To obtain suﬃcient cell number for the ﬂow cytometric
analysis, XF/SF cells were analyzed only after 7 days of
exposure to MMC.
3.2. Cell Morphology. The eﬀect of MMC on cell morphology
was evident in all studied culture conditions; cells adopted
a rounded morphology and became larger in size under
MMC. In particular, the morphology of XF/SF-expanded
ASCs changed dramatically under MMC (Figure 3(a)).
Cell numbers were dramatically decreased especially in
XF/SF conditions under MMC compared with those in
standard cultures. Cells with several extensions and multiple
nuclei were also observed in XF/SF medium under MMC
(Figure 3(a), inset).
3.3. Cell Number. ASCs were expanded under the presence
or absence of MMC (±MMC) from passages 1 to 3 in FBS
and HS media and from passages 2 to 4 in XF/SF media
(Figure 1). The DNA amount indicating cell number
(Figure 3(b)) was analyzed at passage 4. The signiﬁcantly
increased cell number was detected from day 1 to day 11
in each culture condition (Figure 3(b)), except in XF/SF
medium under MMC (XF/SF+MMC). Moreover, a signif-
icantly higher cell number was observed under standard
cultures in XF/SF conditions compared with that under
standard FBS (p < 0 001) and HS (p < 0 05) cultures (XF/
SF−MMC versus FBS−MMC and HS−MMC) at each time
points—days 1, 4, 7, and 11. Cell numbers were also signiﬁ-
cantly increased in standard HS media (HS−MMC versus
HS+MMC) at day 1 (p < 0 05) and in standard FBS media
(FBS−MMC versus FBS+MMC) at days 4 (p < 0 05), 7, and
11 (p < 0 001) compared with those in MMC cultures. Under
MMC, at time points—days 7 and 11—the cell number was
signiﬁcantly higher in HSmedia (p < 0 05) than in FBSmedia
(HS+MMC versus FBS+MMC). The proliferation of ASCs
in XF/SFmedia underMMCwas studied with only one donor
because the cells derived from the other three donors could
not be expanded under MMC in XF/SF conditions. A
decrease in cell number in XF/SF medium under MMC was
evident compared with that in standard XF/SF culture
(Figure 3(b)), but no statistical diﬀerences could be estab-
lished due to the low number of repeats.
3.4. Metabolic Activity. The metabolic activity of ASCs was
measured with CCK-8 assay and normalized to total DNA
by CyQUANT cell proliferation assay (Figure 3(c)). A statis-
tically signiﬁcant increase in metabolic activity in FBS media
under MMC (p < 0 001) was observed at day 1 compared
with that in standard FBS media (FBS+MMC versus
FBS−MMC) (Figure 3(c)). Under MMC, cells in FBS media
had a signiﬁcantly higher metabolic activity compared with
cells in HS media (FBS+MMC versus HS+MMC) at days
4 (p < 0 001), 7, and 11 (p < 0 05) time points. Since MMC
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did not support the proliferation of ASCs in XF/SF media, the
metabolic activity could only be studied with one donor in
XF/SF conditions under MMC (XF/SF+MMC). The meta-
bolic activity increased signiﬁcantly (p < 0 001) over time
(from day 1 to day 11) in each standard culture and under
MMC in FBS media. The metabolic activity also correlated
with the ASC number that was analyzed with the Spearman
correlation test (coeﬃcient 0.78; p < 0 001).
3.5. Multilineage Diﬀerentiation. The osteogenic and adipo-
genic diﬀerentiation capacity was studied using standard
induction protocols under the presence or absence of MMC
(D±MMC) after cell expansion in FBS, HS, and XF/SF
conditions (E±MMC) from passage 1 to 3 (HS and FBS
conditions) and from passage 2 to 3 (XF/SF conditions)
(Figure 1). Chondrogenic diﬀerentiation was studied using
the standard induction only (D−MMC) after cell expansion
under the presence or absence of MMC (D±MMC). Osteo-
genic, adipogenic, and chondrogenic diﬀerentiation was
induced at passage 4. Cells in XF/SF conditions under
MMC did not show eﬃcient diﬀerentiation capacities, which
was in line with signiﬁcantly reduced proliferation capacity
observed under MMC in XF/SF media. Therefore, the results
of XF/SF diﬀerentiations are presented in the supplemental
data (see Supplementary Figure 1 in Supplementary Material
available online at https://doi.org/10.1155/2017/6909163) and
the multilineage diﬀerentiation results of FBS and HS cells
are presented in Figures 4–6.
3.6. Osteogenic Diﬀerentiation. In FBS media, the addition of
MMC during the induction phase signiﬁcantly increased
osteogenic diﬀerentiation (p < 0 05) in cells that had been
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Figure 2: Surface marker expression of undiﬀerentiated ASCs in diﬀerent culture conditions FBS, HS, and XF/SF in standard conditions and
under MMC. (a) The characteristic immunophenotype of ASCs was maintained under MMC- and ASC-expressed stem markers CD73,
CD90, and CD105 in all studied conditions. (b) ASCs showed no expression of CD3, CD11a, CD14, CD19, CD80, CD86, and HLA-DR in
all conditions. The expression of marker CD54 was signiﬁcantly increased under MMC culture in every culture condition (p < 0 05). On
average, ASCs showed low to moderate expression for hematopoietic progenitor stem cell marker CD34. Immunophenotype of
ASCs was analyzed using ﬂow cytometry at passage 3. Data are presented as mean± SD. FBS, fetal bovine serum; HS, human
serum; XF/SF, xeno-free/serum-free; MMC, macromolecular crowding.
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Figure 3: Morphology, cell number, and metabolic activity of ASCs under diﬀerent culture conditions. (a) ASCs cultured under MMC
adopted rounded morphology and became larger in size. The cell number under MMC in XF/SF cultures signiﬁcantly decreased compared
with that in standard cultures. Passage = 3. Scale bar 500 μm (100 μm in XF/SF inset). (b) The DNA amount indicating cell number in
diﬀerent culture conditions was analyzed with CyQUANT cell proliferation assay. Fluorescence signals were measured at 480/520 nm. A
signiﬁcantly higher cell number was observed in standard HS media at day 1 and in standard FBS media at days 4 and 7 and compared
with that in MMC cultures. Under MMC, at time points—day 7 and 11—the cell number was signiﬁcantly higher in HS media compared
with that in FBS media. A signiﬁcantly higher cell number was observed under standard cultures in XF/SF conditions compared with that
in standard FBS and HS cultures at each time point—days 1, 4, 7, and 11. (c) The metabolic activity of ASCs was studied with CCK-8
assay and normalized to total DNA quantiﬁed by CyQUANT cell proliferation assay. Fluorescence signals were measured at 450 nm. A
statistically signiﬁcant increase in metabolic activity in FBS media under MMC was observed at day 1 compared with that in standard FBS
media. ASCs in FBS media under MMC had a signiﬁcantly higher metabolic activity compared with cells in HS media under MMC
at days 4, 7, and 11 time points. Although a decreased cell number and metabolic activity was observed in XF/SF medium under
MMC, no statistical diﬀerences could be established due to the low number donors that survived under MMC. ∗ indicates p < 0 05;
∗∗ indicates p < 0 001. Data are presented as mean± SD. FBS, fetal bovine serum; HS, human serum; XF/SF, xeno-free/serum-free;
MMC, macromolecular crowding.
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expanded in MMC-free media (E−MMC and D+MMC
versus E−MMC and D−MMC; Figure 4) analyzed using
quantitative Alizarin red staining. Signiﬁcantly increased
osteogenic diﬀerentiation (p < 0 05) was observed in cells
expanded in MMC-free media and induced under MMC
compared with cells expanded under MMC and induced in
MMC-free media in FBS condition (E−MMC and D+MMC
versus E+MMC and D−MMC; Figure 4). Nevertheless,
the HS conditions had a superior osteogenic diﬀerentiation
(p < 0 05) compared with the FBS conditions (Figure 4).
There were no statistical diﬀerences observed between dif-
ferent HS induction groups (Figure 4(b)), indicating that
the addition of MMC had no signiﬁcant eﬀect on osteo-
genic diﬀerentiation in HS media. Signiﬁcant osteogenic
diﬀerentiation was observed in all HS and FBS conditions
compared to their respective noninduced (negative control)
cultures (Supplementary Figure 2).
3.7. Adipogenic Diﬀerentiation. The adipogenic diﬀerentia-
tion was analyzed using a Nile red staining that was nor-
malized to cell number. In FBS and HS conditions, ASCs
that had been expanded in MMC-free media accumulated
signiﬁcantly more lipid content under induction with MMC
(p < 0 05) compared with those in standard induction
(E−MMC and D+MMC versus E−MMC and D−MMC;
Figures 5(a) and 5(b)). Increased adipogenesis induced under
MMC was also observed in ASCs that had been expanded in
MMC media compared with that in standard induction
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Figure 4: Alizarin red staining indicating the osteogenic diﬀerentiation potential of ASCs under diﬀerent conditions. (a) Osteogenic
diﬀerentiation was studied using quantitative Alizarin red staining after 28 days of osteogenic induction. (b) Alizarin red staining was
quantiﬁed using cetylpyridinium chloride extraction. ASCs expanded in HS medium had stronger osteogenic diﬀerentiation capacity
compared with those in FBS cultures. FBS cells expanded in standard medium and diﬀerentiated under MMC had a signiﬁcantly stronger
osteogenic diﬀerentiation capacity compared with cells expanded in standard or MMC cultures and diﬀerentiated in standard induction
media. ASCs cultured in HS conditions had a strong osteogenic diﬀerentiation capacity in all studied conditions. Scale bar
500μm; ∗ indicates p < 0 05. Data are presented as mean± SD. FBS, fetal bovine serum; HS, human serum; E±MMC, expansion
under macromolecular crowding/in standard medium; D±MMC, diﬀerentiation under macromolecular crowding/in standard medium.
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Figure 5: Quantitative Nile red staining indicating the adipogenic diﬀerentiation and collagen IV staining indicating adipogenic matrix
deposition under diﬀerent conditions. (a) The adipogenic diﬀerentiation was analyzed using Nile red staining that was normalized to cell
number (b). In FBS and HS conditions, ASCs accumulated signiﬁcantly more lipid content under induction with MMC compared with
those under standard induction. A stronger diﬀerentiation was observed in HS media compared with that in FBS media in each induction
group and signiﬁcantly more lipid droplets were observed in standard HS induction media compared with those in standard FBS
induction. Scale bar 500 μm; ∗ indicates p < 0 05; ∗∗ indicates p < 0 001. Data are presented as mean± SD. (c) Matrix deposition was
evaluated using Col IV staining after adipogenic induction. Col IV deposition was enhanced under MMC induction compared with
induction under MMC-free media in both FBS and HS conditions. Additionally, Col IV was more enhanced in HS media compared with
that in FBS media based on qualitative analysis. Col IV deposition was in line with the results of lipid droplet accumulation that was
conﬁrmed using Nile red staining. Scale bar 500 μm. FBS, fetal bovine serum; HS, human serum; E±MMC, expansion under
macromolecular crowding/in standard medium; D±MMC, diﬀerentiation under macromolecular crowding/in standard medium.
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(E+MMC and D+MMC versus E+MMC and D−MMC;
Figures 5(a) and 5(b)) although not quantitatively signiﬁcant.
Interestingly, cells that had been expanded under MMC and
induced under MMC-free media showed an increased capac-
ity for adipogenesis (p < 0 05), compared with cells that were
expanded in MMC-free media (E+MMC and D−MMC
versus E−MMCandD−MMC; Figures 5(a) and 5(b)). Addi-
tionally, signiﬁcantly more lipid droplets were observed in
HS media (p < 0 001) compared with those in FBS media
in standard inductions (HS E−MMC and D−MMC versus
FBS E−MMC and D−MMC). Compared with that in
noninduced (negative control) cultures of the same treat-
ment group, signiﬁcantly stronger adipogenic diﬀerentiation
was observed in all conditions in FBS and HS media
(Supplementary Figure 3).
MMC increased the deposition of matrix Col IV, which
was evaluated using Col IV immunoﬂuorescence staining
after 21 days of adipogenic induction (Figure 5(c)). Col IV
deposition was enhanced under MMC induction compared
with that under standard adipogenic induction in both FBS
and HS media (E±MMC and D+MMC versus E±MMC
and D−MMC; Figure 5(c)). Additionally, Col IV deposition
was enhanced in HS media compared with that in FBS
media in all conditions, which was in line with the stron-
ger adipogenic diﬀerentiation observed in HS media. Based
on the qualitative Col IV staining, the amount of Col IV
was dependent on the adipogenic diﬀerentiation eﬃciency.
Also in XF/SF conditions, Col IV was more deposited
under MMC induction compared with standard induction
(E−MMC and D+MMC versus E−MMC and D−MMC;
Supplementary Figure 1).
3.8. Chondrogenic Diﬀerentiation. Chondrogenic diﬀerentia-
tion of ASCs was evident in all studied culture conditions.
However, more proteoglycans were deposited after expansion
in standard conditions based on qualitative Alcian blue stain-
ing. A less dense histological architecture of the micromass
pellet was formed by the cells that were expanded under
MMC prior to diﬀerentiation (Figure 6).
4. Discussion
Previous studies have demonstrated that MMC will increase
the thermodynamic activities and biological processes by
several orders of magnitude and will promote cells to recreate
a more robust microenvironment in vitro [5, 38]. Our
current study demonstrates the eﬀect of MMC on ASC
proliferation and diﬀerentiation under clinically relevant
culture conditions. This is a novel approach and the inﬂuence
of MMC on ASC characteristics has not been previously
reported. However, we and others have shown that diﬀerent
culture conditions greatly inﬂuence ASC proliferation and
diﬀerentiation capacity [24, 29, 30, 39]. As cell-based treat-
ments are becoming more common, eﬃcient in vitro cell
expansion and diﬀerentiation methods are important to
achieve an optimal and predictable clinical outcome.
In previous studies using human BM-MSCs, the beneﬁts
of MMC have been demonstrated by increased proliferation
as well as eﬃcient adipogenic diﬀerentiation [2, 3, 40].
Although most of the published studies have focused on the
positive aspects of MMC, undesirable eﬀects also exist such
as protein destabilization and aggregate formation as recently
reviewed [41]. Our current results demonstrate both positive
H
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Figure 6: Alcian blue staining indicating the chondogenic diﬀerentiation of ASCs under diﬀerent conditions. Qualitative Alcian blue staining
suggested that proteoglycans were more deposited after expansion in standard conditions compared with expansion under MMC. A less
dense histological architecture of the micromass pellet was observed on cells that were expanded under MMC prior to diﬀerentiation.
Scale bar 50μm. FBS, fetal bovine serum; HS, human serum; E±MMC, expansion under macromolecular crowding/in standard medium.
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and inhibitory eﬀects of MMC on ASC behavior in culture
from the viewpoint of expanding cells to reach therapeuti-
cally relevant numbers. Reduced proliferation capacity under
MMC was observed in all studied culture conditions com-
pared with that in standard cultures; on the other hand,
strong diﬀerentiation capacity was detected under MMC
(see next). The undesirable eﬀects of MMC were obvious in
XF/SF conditions as a signiﬁcantly reduced proliferation
capacity. In fact, cells expanded in standard XF/SF conditions
had superior proliferation rates compared with cells cultured
in standard FBS and HS cultures; however, proliferation of
XF/SF cells was clearly reduced under MMC. Interestingly,
ASCs expanded in FBS conditions under MMC showed
increased metabolic activity compared with those in standard
FBS cultures, whereas the metabolic activity in HS and XF/SF
cultures was similar under MMC and in standard HS and
XF/SF cultures.
Furthermore, changes in ASC morphology under MMC
were evident in all culture conditions with cells adopting a
larger size and more rounded shape. The major eﬀect of
MMCwas observed in XF/SF cultures where cell morphology
was changed under MMC. As cell number was signiﬁcantly
decreased in XF/SF conditions under a longer-term MMC
exposure, the cells became large and round with many
extensions with several nuclei observed occasionally. Similar
observations have not been reported earlier as our study is
the ﬁrst to report use of MMC with XF/SF-cultured ASCs.
The results showed that MMC method is not optimal for
studied XF/SF cultures.
As the previous reports of increased proliferation rates
under MMC were performed with BM-MSCs in FBS-
containing media, this may explain the diﬀerent outcomes.
The MMC functions via EVE that is dependent on the
FVO, which is deﬁned as the fraction of the total volume
occupied by macromolecules [3]. A use of a mixture of 70
and 400 kDa Ficoll as a crowding agent was ﬁrst reported
by Chen et al. who calculated the ﬁnal concentration of mac-
romolecules to a level corresponding to blood plasma protein
concentrations that is approximately 80mg/mL [3]. The
FVO is calculated as optimal for BM-MSCs, and calculations
are performed using the albumin concentrations of blood
serum as a baseline. Thus, FVO should probably be further
optimized for ASC cultures. Additionally, the eﬀect of
diﬀerent serum conditions may change the equilibrium of
the optimized FVO. As previously described, the basis for
MMC function is its ability to support cells in recreating their
own microenvironment in vitro [2, 3]. However, cells that
produce naturally less ECM may not be induced to build
the microenvironment even under MMC [3], which may
apply to ASCs. Furthermore, it can be speculated that the
ECM production is reduced in chemically deﬁned XF/SF
cultures hindering the suitability of MMC methods for
XF/SF cells. Also, the weaker cell adherence that was
speculated in XF/SF conditions [30] may interfere with
the eﬀects of MMC.
Due to low-metabolic activity of cells in XF/SF conditions
under MMC, ﬂow cytometric analysis was performed after a
7-day exposure to MMC. The immunophenotype of ASCs
that were cultured in HS- and FBS-supplemented media
was analyzed after culture from passage 1 to 3 under MMC.
Overall, the characteristic immunophenotype of ASCs was
maintained under MMC in all of the studied culture condi-
tions. Low to moderate expression was observed for CD34
as reported previously [42, 43]. Based on our current results,
the expression of CD34 appears to be more dependent on the
culture media formulation than MMC exposure. Interest-
ingly, the expression of CD54 was signiﬁcantly higher under
MMC in all of the studied culture conditions. CD54 is an
intercellular adhesion molecule 1 (ICAM-1) that is typically
expressed on endothelial cells and cells of the immune system
and is involved in stabilizing cell-cell interactions, for
example, in leukocyte and MSC interactions as previously
reported [44]. However, more studies on cell-cell interactions
and immunogenic properties of ASCs under MMC are
required to demonstrate how increased CD54 expression
translates to a speciﬁc function of ASCs.
In good agreement with previous studies, the ECM was
found to be extensively deposited under MMC leading to
more mature ECM [2, 3]. Under MMC, the intra- and extra-
cellular proteins become aligned and the eﬀect is maintained
even in the absence of cellular interaction [1]. The ECM in
turn aﬀects cell-matrix interactions and promotes stronger
cell adhesion, thus having an inﬂuence on the formation
and structure of the cytoskeleton [1]. The current study dem-
onstrates that the eﬃciency of adipogenic diﬀerentiation is in
line with the deposition of matrix proteins, especially Col IV
that is a major matrix component in adipocytes. This result
indicates that a more mature state of ECM is produced under
MMC. Additionally, culture condition (serum versus XF/SF
condition) has an eﬀect on the deposition of ECM proteins.
In our study, more Col IV was deposited in HS media com-
pared with that in FBS and XF/SF condition; however, the
deposition of ECM proteins is likely associated with the
more eﬃcient diﬀerentiation that was observed in HS
media.
While MMC exposure did not enhance ASC proliferation
in the present study, a more eﬃcient osteogenic and adipo-
genic diﬀerentiation was observed in FBS and HS cultures.
In FBS conditions, cells had a signiﬁcantly stronger osteogenic
diﬀerentiation capacity under MMC induction compared
with induction in standard conditions. Additionally, ASCs
accumulated signiﬁcantly more lipid droplets under MMC
induction compared with induction under standard condi-
tions. This result indicates the supportive inﬂuence of MMC
on adipogenic and/or osteogenic commitment of ASCs in
serum-containing medium. As previously demonstrated
using BM-MSCs, crowding facilitates microenvironment
formation and stabilizes or drives diﬀerentiation [2]. Ang
et al. showed that the ECM was extensively remodeled
toward a proadipogenic microenvironment under MMC
in adipogenic induction media, which further promoted a
strong adipogenic diﬀerentiation.
In contrast, our results showed that ASCs cultured in
XF/SF conditions did not respond to MMC during diﬀer-
entiation induction. Signiﬁcant diﬀerences in the intensity
of osteogenic diﬀerentiation were also observed between
HS and FBS media, with stronger osteogenic diﬀerentiation
observed in HS medium compared with those in FBS
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medium. In line with this result, similar diminished osteo-
genic diﬀerentiation potential of ASCs cultured in FBS
medium compared with HS medium has been reported pre-
viously by our group [25]. Our current results highlight the
superior osteogenic potential of ASC-expanded HS-based
medium compared to that of FBS conditions.
Both FBS and HS contain an undeﬁned cocktail of
growth factors and serum proteins and the composition
varies between diﬀerent serum lots. There are several studies
on ASC culture in both FBS and HS, where lot-to-lot varia-
tion is evident [23–25, 39]. The majority of these studies
suggest that cells expanded in HS medium show stronger
osteogenic potential compared with cells expanded in FBS
medium. We have previously shown that diﬀerent culture
conditions greatly inﬂuence proliferation and diﬀerentiation
capacity of ASCs [30]. Thus, apart from the eﬀects of
MMC, cell viability, proliferation capacity, ECM composi-
tion, and trilineage diﬀerentiation potential are aﬀected by
a chosen culture condition. This eﬀect was also evident in
the current study.
Moreover, chondrogenic diﬀerentiation was studied in
standard induction media after cell expansion both in
standard media and under MMC. Based on qualitative
Alcian blue staining, ASCs that were expanded in standard
media had stronger capacity for chondrogenic diﬀerentiation
compared with cells expanded under MMC, which was
shown in stronger deposition of proteoglycans after standard
cell expansion. The micromass pellet structure was also
altered depending on culture condition, and cells expanded
under MMC had less dense histological structure. The
observed structural changes may be due to an increased
remodeling activity under MMC as seen previously with
adipogenic diﬀerentiation [2] which is based on matrix
metalloproteinase activity. A less dense and more ﬁbrous-
like structure of the micromass pellet that was formed under
MMC may not be speciﬁc for cartilage tissue; but on the
other hand, the altered structure resembles a lacuna-like
architecture that is typical for cartilage tissue. More studies
should be performed to draw a conclusion on the crowding
eﬀects on chondrogenic diﬀerentiation potential of cells.
5. Conclusions
Careful characterization of ASC behavior with regard to
clinically relevant in vitro culture conditions is highly impor-
tant for the progress of cell-based therapies. In the current
work, MMCwas studied as an alternative method to facilitate
ASC diﬀerentiation and proliferation. A strong capacity
for osteogenic and adipogenic diﬀerentiation was observed
for ASCs under MMC in serum-containing media, and
thus, MMC is recommended to be used to enhance the
diﬀerentiation capacity of ASC. Nevertheless, cell expansion
should be performed in standard conditions. The ASC
immunophenotype was maintained under MMC except the
signiﬁcantly increased expression of CD54. In conclusion,
our results highlighted both supportive and inhibitory eﬀects
of MMC on ASC behavior and a success of MMC treatment
appeared to be culture condition dependent. Still, novel
methods to guide and strengthen ASC diﬀerentiation are
desired and required. Our current study demonstrated that
MMC is a potential technique to drive diﬀerentiation by
modifying the ECM, which directly appears to modify cell
morphology and to have an inﬂuence on the determination
of a cell’s fate.
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